Acceleron Pharma Incの営業利益
Acceleron Pharma Incの営業利益は何ですか。
Acceleron Pharma Incの営業利益は-226.57%です。
営業利益の定義は何ですか。
営業利益率は、営業利益を純売上高で除したもので、パーセントで表しています。
Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.
NASDAQのセクタHealth Careにおける営業利益の企業と比べるAcceleron Pharma Inc
Acceleron Pharma Incは何をしますか。
Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.
Acceleron Pharma Incと類似の営業利益
- CHF Solutions Incの営業利益は-228.85%です。
- ShiftPixy Incの営業利益は-228.57%です。
- BridgeBio Pharma Incの営業利益は-228.56%です。
- International Zeoliteの営業利益は-228.51%です。
- Fiore Cannabisの営業利益は-227.89%です。
- Leaf Resourcesの営業利益は-227.03%です。
- Acceleron Pharma Incの営業利益は-226.57%です。
- Pacific Biosciences of California Incの営業利益は-225.81%です。
- Visionstateの営業利益は-225.69%です。
- Frequency Exchangeの営業利益は-225.62%です。
- Branding Chinaの営業利益は-225.18%です。
- China Healthの営業利益は-224.68%です。
- Buruの営業利益は-224.64%です。